Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
129 hedge funds and large institutions have $717M invested in Flexion Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 18 closing their positions.
197% more call options, than puts
Call options by funds: $6.65M | Put options by funds: $2.24M
17% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 36
1% less funds holding
Funds holding: 130 → 129 (-1)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
26% less capital invested
Capital invested by funds: $973M → $717M (-$256M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$29.2M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$14.9M |
| 3 |
CC
Carlson Capital
Dallas,
Texas
|
+$10.4M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$5.48M |
| 5 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$5.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$18.1M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$11.9M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$11.8M |
| 4 |
PP
Peconic Partners
New York
|
-$10.9M |
| 5 |
PA
Perceptive Advisors
New York
|
-$7.96M |
FLXN Hedge Fund Activity: Q3 2018 in Review
129 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q3 2018, worth a combined $717M — down 26% from $973M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FLXN and 17 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 42 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $29.2M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $18.1M.
- 129 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q3 2018, down from 130 in Q2 2018.
- Funds reported $717M of Flexion Therapeutics, Inc. stock for Q3 2018, down 26% quarter-over-quarter.
- 17 funds opened new Flexion Therapeutics, Inc. positions in Q3 2018 and 18 closed out, a net change of -1 holder.
- The largest Flexion Therapeutics, Inc. buyer in Q3 2018 was Point72 Asset Management, an estimated $29.2M added.
- The largest Flexion Therapeutics, Inc. seller in Q3 2018 was Gilder Gagnon Howe & Co, an estimated $18.1M sold.
Based on aggregated 13F filings for Q3 2018.